We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
14 hedge funds and large institutions have $4.11M invested in Plus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
473% more capital invested
Capital invested by funds: $718K → $4.11M (+$3.4M)
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
75% more funds holding
Funds holding: 8 → 14 (+6)
0.01% more ownership
Funds ownership: 0.01% → 0.02% (+0.01%)
Holders
14
Holders Change
+6
Holders Change %
+75%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.53M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$315K |
| 3 |
Two Sigma Advisers
New York
|
+$276K |
| 4 |
Two Sigma Investments
New York
|
+$261K |
| 5 |
VF
Virtu Financial
New York
|
+$183K |
Top Sellers
| 1 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
-$29K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$3.61K |
